Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinoma
Open Access
- 13 September 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 113 (2) , 198-206
- https://doi.org/10.1002/ijc.20566
Abstract
Tissue inhibitor of matrix metalloproteases 1 (TIMP‐1) inhibits the proteolytic activity of matrix metalloproteases and hereby prevents cancer invasion. However, TIMP‐1 also possesses other functions such as inhibition of apoptosis, induction of malignant transformation and stimulation of cell‐growth. We have previously demonstrated that TIMP‐1 is elevated in blood from colorectal cancer patients and that high TIMP‐1 levels predict poor prognosis. To clarify the role of TIMP‐1 in colorectal tumorigenesis, the expression pattern of TIMP‐1 in benign and malignant colorectal tumors was studied. In all of 24 cases of colorectal adenocarcinoma TIMP‐1 mRNA was detected by in situ hybridization. In all cases TIMP‐1 expression was found in fibroblast‐like cells located at the invasive front but was seen only sporadically in normal mucosa. No TIMP‐1 mRNA was seen in any of the cases in benign or malignant epithelial cells, in vascular cells or smooth muscle cells. Comparison of sections processed for TIMP‐1 in situ hybridization with sections immunohistochemically stained with antibodies against TIMP‐1 showed good correlation between TIMP‐1 mRNA and immunoreactivity. Combining TIMP‐1 in situ hybridization with immunohistochemical staining for α‐smooth muscle actin or CD68 showed TIMP‐1 mRNA in myofibroblasts but not in macrophages. TIMP‐1 mRNA was detected in 2 of 7 adenomatous polyps in the adenoma area: in both cases associated with focal stromal inflammation at the epithelial‐stromal interface. In conclusion, TIMP‐1 expression is a rare event in benign human colon tissue but is highly expressed by myofibroblasts in association with invading colon cancer cells.Keywords
Funding Information
- The Danish Cancer Society
- European Commission (QLG1-CT-2000-0111131)
- Weimann Foundation
This publication has 33 references indexed in Scilit:
- Leading-Edge Myofibroblasts in Human Colon Cancer Express Plasminogen Activator Inhibitor-1American Journal of Clinical Pathology, 2004
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.Journal of Clinical Investigation, 1998
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomasDiseases of the Colon & Rectum, 1996
- Expression and localization of matrix‐degrading metalloproteinases during colorectal tumorigenesisMolecular Carcinogenesis, 1994
- The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproductionJournal of Neuro-Oncology, 1994
- Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13Biochemistry, 1992
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activityNature, 1985
- A better cell line for making hybridomas secreting specific antibodiesNature, 1978